Table 1 Main clinical and laboratory characteristics of FPLD subclasses

From: Clinical Utility Gene Card for: Familial partial lipodystrophy

FPLD type (gene involved)

Transmission

Clinical onset of disease

Clinical lipodystrophy

Common signs to all FPLD

Signs of metabolic severity

Possible additional signs

FPLD1 (unknown)

Unknown

Childhood or adulthood

Only described in women

Lipoatrophy of buttocks and lower limbs

Truncal obesity

FPLD1 to 6: Insulin resistance, diabetes, non-alcoholic fatty liver disease, high triglycerides, low HDL-cholesterol

FPLD1 to 5: Acanthosis nigricans, muscular appearance, prominent veins in limbs, acute pancreatitis, high blood pressure

±hyperandrogenism, polycystic ovaries, atherosclerosis, low leptin and adiponectin levels

FPLD2 (LMNA)

Autosomal dominant

Around puberty

Lipoatrophy of buttocks, limbs and trunk

Accumulation of cervicofacial subcutaneous and/or intra-abdominal fat

Subcutaneous lipomas

  

Skeletal and cardiac muscular dystrophy and/or premature ageing (mainly in patients with non-Arg482 mutations)

FPLD3 (PPARG)

Autosomal dominant

Adulthood

Lipoatrophy of buttocks and limbs

Accumulation of intra-abdominal fat

  

Very high blood pressure

Severe generalized lipoatrophic syndrome with renal insufficiency (one patient described with a biallelic mutation)

FPLD4 (PLIN1)

Autosomal dominant

Childhood or adulthood (five unrelated families described)

Lipoatrophy of buttocks and limbs

  

FPLD5 (CIDEC)

Autosomal recessive

Childhood (one case described)

Lipoatrophy of buttocks and limbs

  

Ketosis-prone diabetes

FPLD6 (LIPE)

Autosomal recessive

Adulthood (two unrelated families describeds)

Decreased lower-extremity fat

Increased visceral fat

 

Muscular dystrophy